Xilio Therapeutics, Inc. Shareholders' Equity
Xilio Therapeutics, Inc. (XLO) had Shareholders' Equity of $72.26 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $72.26M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $72.55M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $35.27M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$8.10M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $72.26M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $72.55M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $35.27M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | -$8.10M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $7.07M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $10.70M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $17.60M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | $20.97M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $33.42M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $25.77M 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $36.83M 10-K · filed 2026-03-23 | |
| 2023-09-30 | $52.50M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $67.38M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $84.79M 10-Q · filed 2024-08-08 | |
| 2022-12-31 | $105.65M 10-K · filed 2025-03-11 | |
| 2022-09-30 | $126.30M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $144.22M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $166.12M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $185.43M 10-K · filed 2024-04-01 | |
| 2021-09-30 | -$136.46M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | -$121.31M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | -$99.14M 10-Q · filed 2022-11-09 | -$99.14M 10-Q · filed 2021-12-02 |
| 2020-12-31 | -$83.29M 10-K · filed 2023-03-02 | |
| 2020-09-30 | -$63.03M 10-Q · filed 2021-12-02 | |
| 2020-06-30 | -$48.90M 10-Q · filed 2021-12-02 | |
| 2020-03-31 | -$37.55M 10-Q · filed 2021-12-02 | |
| 2019-12-31 | -$29.52M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 |